Why is Fischer Medical falling/rising?

As of 04-Sep, Fischer Medical Ventures Ltd is experiencing a price increase, currently at 1,091.10, reflecting a rise of 23.55 or 2.21%. The stock has recently hit a new 52-week high of Rs. 1110 and has outperformed its sector by 3.1%. Over the last four days, it has gained 4.68%, opening with a 3.5% gain today. The stock's performance over various periods shows significant strength, with a year-to-date increase of 53.82% and a staggering 1,604.84% rise over the past three years. Positive financial results, including a 247.89% growth in net sales and a low debt-to-equity ratio, contribute to the stock's upward momentum. However, concerns about management efficiency, indicated by a low return on equity of 1.39% and a high price-to-book value ratio, may temper investor enthusiasm.
In the broader market context, Fischer Medical's short-term performance of +4.37% over the past week significantly outpaces the Sensex, which has only increased by 0.80%. This strong relative performance suggests that investor sentiment towards Fischer Medical is robust compared to the overall market. Despite the positive returns, the lack of domestic mutual fund investment may indicate some caution among institutional investors regarding the stock's valuation and management efficiency. Overall, while the stock is currently rising, these underlying risks could influence future price movements.